Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791127 · ClinicalTrials.gov registry record
Safety and Performance Study of the Siello S Pacing Lead
A clinical trial, sponsored by Biotronik.
- Terminated
- Registry status
- 1,758
- Enrollment target
NCT01791127 is a clinical trial that was terminated before completion, run by Biotronik. The registered enrollment target is 1,758 participants.
The verdict
NCT01791127 was terminated before completion, sponsored by Biotronik.
- TERMINATED
- Registry status
- 1,758 participants
- Enrollment target
Study Summary
The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.
Interventions
- DEVICE market-released BIOTRONIK pacemaker system including one or two Siello S leads.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,758 participants |
| Start Date | 2013-03-13 |
| Est. Completion | 2019-04-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01791127
The ClinicalTrials.gov registry entry for NCT01791127 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,758 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which market-released BIOTRONIK pacemaker system including one or two Siello S leads. is the first listed.
NCT01791127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01791127 about?
NCT01791127 is a clinical study titled "Safety and Performance Study of the Siello S Pacing Lead". The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.
What is the current status of trial NCT01791127?
This trial is currently terminated. The enrollment target is 1,758 participants. The study started on 2013-03-13. Estimated completion is 2019-04-17.
What interventions are being tested in trial NCT01791127?
The interventions under investigation include: market-released BIOTRONIK pacemaker system including one or two Siello S leads. (DEVICE).
Who is sponsoring clinical trial NCT01791127?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.